SYNDAX PHARMACEUTICALS INC

Ticker: SNDX CUSIP: 87164F105 Class: Common Stock

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 515,129 Value ($000) $10,823 Avg Close $17.45 Range $12.99 - $22.73

Q3 2025

Shares 124,575 Value ($000) $1,916 Avg Close $13.09 Range $8.59 - $17.24

Q2 2025

Shares 28,227 Value ($000) $264 Avg Close $11.01 Range $8.58 - $14.24

Q1 2025

Shares 60,337 Value ($000) $741 Avg Close $14.10 Range $12.06 - $16.95

Q4 2024

Shares 14,071 Value ($000) $186 Avg Close $17.11 Range $12.40 - $22.50

Q3 2024

Shares 22,685 Value ($000) $437 Avg Close $20.66 Range $17.34 - $25.07

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	515,129	$10,823	$17.45	$12.99 - $22.73
Q3 2025	124,575	$1,916	$13.09	$8.59 - $17.24
Q2 2025	28,227	$264	$11.01	$8.58 - $14.24
Q1 2025	60,337	$741	$14.10	$12.06 - $16.95
Q4 2024	14,071	$186	$17.11	$12.40 - $22.50
Q3 2024	22,685	$437	$20.66	$17.34 - $25.07